Development of a platform process for adenovirus purification that removes human set and nucleolin and provides high purity vector for gene delivery

Biotechnology and Bioengineering

Volumn 110, Issue 3, 2013, Pages 848-856

  Riske, Frank ^a   Berard, Nicole ^a   Albee, Karen ^a   Pan, Peng ^a   Henderson, Mike ^a   Adams, Kris ^a   Godwin, Simon ^a   Spear, Sherri ^a  

^a SANOFI   (France)

Author keywords

Adenovirus; Gene therapy; Nucleolin; Platform; Purification process; SET

Indexed keywords

ADENOVIRUS; NUCLEOLIN; PLATFORM; PURIFICATION PROCESS; SET;

GENE THERAPY; GENE TRANSFER; PROTEINS; REMOVAL; VIRUSES;

PURIFICATION;

NUCLEOLIN; PROTEIN; PROTEIN SET; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; BIOREACTOR; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE THERAPY; HOST CELL; HUMAN; HUMAN CELL; NONHUMAN; PURIFICATION; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; GENETIC THERAPY; GENETIC VECTORS; HISTONE CHAPERONES; HUMANS; PHOSPHOPROTEINS; RNA-BINDING PROTEINS; TECHNOLOGY, PHARMACEUTICAL; TRANSCRIPTION FACTORS;

ADENOVIRIDAE;

EID: 84872667138     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.24742     Document Type: Article

References (35)

1. Albinana-Gimenez N, Clemente-Casares P, Calgua B, Huguet JM, Courtois S, Girones R. 2009. Comparison of methods for concentrating human adenoviruses, polyomavirus JC and noroviruses in source waters and drinking water using quantitative PCR. J Virol Methods 158(1-2): 104-109.
2. Barrijal S, Perros M, Gu Z, Avalosse BL, Belenguer P, Amalric F, Rommelaere J. 1992. Nucleolin forms a specific complex with a fragment of the viral (minus) strand of minute virus of mice DNA. Nucleic Acids Res 20(19): 5053-5060.
3. Beresford PJ, Zhang D, Oh DY, Fan Z, Greer EL, Russo ML, Jaju M, Lieberman J. 2001. Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-stranded DNA nicks. J Biol Chem 276(46): 43285-43293.
4. Blanche F, Cameron B, Barbot A, Ferrero L, Guillemin T, Guyot S, Somarriba S, Bisch D. 2000. An improved anion-exchange HPLC method for the detection and purification of adenoviral particles. Gene Ther 7(12): 1055-1062.
5. Bugler B, Caizergues-Ferrer M, Bouche G, Bourbon H, Amalric F. 1982. Detection and localization of a class of proteins immunologically related to a 100-kDa nucleolar protein. Eur J Biochem 128(2-3): 475-480.
6. Burova E, Ioffe E. 2005. Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: Methods and implications. Gene Ther 12(Suppl. 1): S5-S17.
7. Duffy AM, O'Doherty AM, O'Brien T, Strappe PM. 2005. Purification of adenovirus and adeno-associated virus: Comparison of novel membrane-based technology to conventional techniques. Gene Ther 12(Suppl. 1): S62-S72.
8. Eglon MN, Duffy AM, O'Brien T, Strappe PM. 2009. Purification of adenoviral vectors by combined anion exchange and gel filtration chromatography. J Gene Med 11(11): 978-989.
9. Fujii-Nakata T, Ishimi Y, Okuda A, Kikuchi A. 1992. Functional analysis of nucleosome assembly protein, NAP-1. The negatively charged COOH-terminal region is not necessary for the intrinsic assembly activity. J Biol Chem 267(29): 20980-20986.
10. Ginisty H, Sicard H, Roger B, Bouvet P. 1999. Structure and functions of nucleolin. J Cell Sci 112(Pt 6): 761-772.
11. Goerke AR, To BC, Lee AL, Sagar SL, Konz JO. 2005. Development of a novel adenovirus purification process utilizing selective precipitation of cellular DNA. Biotechnol Bioeng 91(1): 12-21.
12. Graham FL, Smiley J, Russell WC, Nairn R. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36(1): 59-74.
13. Green M, Pina M, Kimes R, Wensink PC, MacHattie LA, Thomas CA, Jr. 1967. Adenovirus DNA. I. Molecular weight and conformation. Proc Natl Acad Sci USA 57(5): 1302-1309.
14. Hehir KM, Armentano D, Cardoza LM, Choquette TL, Berthelette PB, White GA, Couture LA, Everton MB, Keegan J, Martin JM, Pratt DA, Smith MP, Smith AE, Wadsworth SC. 1996. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence. J Virol 70(12): 8459-8467.
15. Hirata D, Iwamoto M, Yoshio T, Okazaki H, Masuyama J, Mimori A, Minota S. 2000. Nucleolin as the earliest target molecule of autoantibodies produced in MRL/lpr lupus-prone mice. Clin Immunol 97(1): 50-58.
16. Huyghe BG, Liu X, Sutjipto S, Sugarman BJ, Horn MT, Shepard HM, Scandella CJ, Shabram P. 1995. Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography. Hum Gene Ther 6(11): 1403-1416.
17. Kawase H, Okuwaki M, Miyaji M, Ohba R, Handa H, Ishimi Y, Fujii-Nakata T, Kikuchi A, Nagata K. 1996. NAP-I is a functional homologue of TAF-I that is required for replication and transcription of the adenovirus genome in a chromatin-like structure. Genes Cells 1(12): 1045-1056.
18. Konz JO, Pitts LR, Sagar SL. 2008. Scaleable purification of adenovirus vectors. Methods Mol Biol 434: 13-23.
19. Laukel M, Rogge P, Dudziak G. 2011. Disposable downstream processing for clinical manufacturing. Bioprocess International 9(S2): 14-21.
20. Lee DS, Kim BM, Seol DW. 2009. Improved purification of recombinant adenoviral vector by metal affinity membrane chromatography. Biochem Biophys Res Commun 378(3): 640-644.
21. Matthews DA. 2001. Adenovirus protein V induces redistribution of nucleolin and B23 from nucleolus to cytoplasm. J Virol 75(2): 1031-1038.
22. Minota S, Jarjour WN, Suzuki N, Nojima Y, Roubey RA, Mimura T, Yamada A, Hosoya T, Takaku F, Winfield JB. 1991. Autoantibodies to nucleolin in systemic lupus erythematosus and other diseases. J Immunol 146(7): 2249-2252.
23. Okuwaki M, Nagata K. 1998. Template activating factor-I remodels the chromatin structure and stimulates transcription from the chromatin template. J Biol Chem 273(51): 34511-34518.
24. Omenn GS. 2004. The Human Proteome Organization Plasma Proteome Project pilot phase: Reference specimens, technology platform comparisons, and standardized data submissions and analyses. Proteomics 4(5): 1235-1240.
25. Peixoto C, Ferreira TB, Carrondo MJ, Cruz PE, Alves PM. 2006. Purification of adenoviral vectors using expanded bed chromatography. J Virol Methods 132(1-2): 121-126.
26. Peixoto C, Ferreira TB, Sousa MF, Carrondo MJ, Alves PM. 2008. Towards purification of adenoviral vectors based on membrane technology. Biotechnol Prog 24(6): 1290-1296.
27. Pontvianne F, Abou-Ellail M, Douet J, Comella P, Matia I, Chandrasekhara C, Debures A, Blevins T, Cooke R, Medina FJ. et al. 2010. Nucleolin is required for DNA methylation state and the expression of rRNA gene variants in Arabidopsis thaliana. PLoS Genet 6(11): e1001225.
28. Roitsch C, Achstetter T, Benchaibi M, Bonfils E, Cauet G, Gloeckler R, L'hôte H, Keppi E, Nguyen M, Spehner D. et al. 2001. Characterization and quality control of recombinant adenovirus vectors for gene therapy. J Chromatogr B Biomed Sci Appl 752(2): 263-280.
29. Santer DM, Yoshio T, Minota S, Moller T, Elkon KB. 2009. Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus. J Immunol 182(2): 1192-1201.
30. Shabram PW, Giroux DD, Goudreau AM, Gregory RJ, Horn MT, Huyghe BG, Liu X, Nunnally MH, Sugarman BJ, Sutjipto S. 1997. Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles. Hum Gene Ther 8(4): 453-465.
31. Szebeni A, Herrera JE, Olson MO. 1995. Interaction of nucleolar protein B23 with peptides related to nuclear localization signals. Biochemistry 34(25): 8037-8042.
32. Tayyari F, Marchant D, Moraes TJ, Duan W, Mastrangelo P, Hegele RG. 2011. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med 17(9): 1132-1135.
33. Waggoner S, Sarnow P. 1998. Viral ribonucleoprotein complex formation and nucleolar-cytoplasmic relocalization of nucleolin in poliovirus-infected cells. J Virol 72(8): 6699-6709.
34. Xue Y, Johnson JS, Ornelles DA, Lieberman J, Engel DA. 2005. Adenovirus protein VII functions throughout early phase and interacts with cellular proteins SET and pp32. J Virol 79(4): 2474-2483.
35. Zhu J, Grace M, Casale J, Chang AT, Musco ML, Bordens R, Greenberg R, Schaefer E, Indelicato SR. 1999. Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector. Hum Gene Ther 10(1): 113-121.